Relationship Between Atrial Fibrillation and Age
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• Women 20 to 79 years old, the risk of stroke is 4.6-fold greater in women than men. In addition, mortality for women with AF is up to 2.5 times greater than that for men.
• Michelena HI, Powell BD, Brady PA, Friedman PA, Ezekowitz MD. Gender in atrial fibrilla-tion: ten years later. Gend Med. 2010;3(7): • 206-217.
• AF sufferers have a five-fold increase in stroke risk compared to the general population. The numbers for women tell a dire story:
• Stroke is 4 th leading cause of death for women • Women account for more than 60% of stroke related deaths • After age 75, 60% of those with AF are women • There have been greater declines in stroke death rates among men than women • Women are also more likely to experience longer symptomatic episodes, more frequent recurrences and significantly higher ventricular rates during AF
• Roy D, Talajic • Stroke risk not greater for women if <65 and no additional stroke risk factors (Lone AF)
• Therefore 50 yo woman with lone AF (CHA2DS2VASC = 1) may not need anticoagulation
• Mikkelsen AP, Lindhardsen J, Lip GY, Gislason GH, Torp-Pedersen C, Olesen JB. Female sex as a risk factor for stroke in atrial fibrillation: a nationwide cohort study. J Thromb Haemost. 2012;10(9):1745-1751.
• Swedish study found that the rate of ischemic stroke in AF patients younger than 65 was 47% high in women than men.
• Friberg L, Benson L, Rosenqvist M, Lip GY. Assessment of female sex as a risk fac-tor in atrial fibrillation in Sweden: nation-wide retrospective cohort study. BMJ. 2012;344:e3522.
• More likely to live with stroke related disability than men and have significantly lower quality of life.
• Why are there gender differences in AF?
• Specific AF related differences • Eg BP is strongly associated with AF in women.
• These differences between men and women with AF may be based in physiology, vascular biology, genetics, hormones, or thromboembolic factors. Certainly, menstrual cycles and hormones play a role in women.
• Volgman AS, Manankil MF, Mookherjee D, Trohman RG. Women with atrial fibrilla-tion: greater risk, less attention. Gend Med. 2009;6(3):419-32.
• Women also live longer than men, placing them in the susceptible age range for AF for a longer amount of time.
• Mason PK, Moorman L, Lake D, et al. Gender and racial characteristics of patients referred to a tertiary atrial fibrillation center. JAFIB. 2010;2(3):827.
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• Euroheart survey found that women with AF have more than double the thromboembolism risk of men the AF.
• Lip GY, Nieuwlaat R, Pisters R, Lane DA, Cri-jns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137:263-72.
• Although heavy alcohol consumption is associated with higher risk of AF among men, there is no such association in women.
• Mukamal KJ, Tolstrup JS, Friberg J, Jensen G, Grønbaek M. Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study. Circulation. 2005;112(12):1736-1742.
Treatment Differences
• Electrocardioversion is used significantly less in women than men • AF ablation referral less for women than men despite similar outcomes
Bleeding and anticoagulation differences
• Women are also at a higher risk than men for AF-related thromboembolism when off of warfarin.
• When it comes to warfarin, men have been found to have lower warfarin adherence rates than women • Warfarin is superior to aspirin in reducing the risk of stroke, especially in women, as it reduces the risk by 84 percent in them compared to 60 percent in men. • However, women over 75 years old were 54 percent less likely to receive warfarin and twice as likely to receive aspirin.
• But what may be even better news for women is that stroke reduction results of the newer novel oral anticoagulants are even stronger than warfarin.
• When looking to prescribe anticoagulant medication to women, additional risk of bleeding shouldn't be a concern. Studies have shown bleeding risk for men and women to be about the same.
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• Rate vs Rhythm control
• Anticoagulation vs no Anticoagulation
RATE vs RHYTHM
• Rate control is default option unless:
-AF that is symptomatic (usually young patients with paroxysmal AF)
-Left ventricular impairment
Anticoagulation vs No Anticoagulation
• CHA2DS2VASC ≥ 1 consider Anticoagulation
• CHA2DS2VASC = 0 No Anticoagulation Take Home Messages
• AF in women is common and risk of stroke and mortality is significantly higher than compared with men
• Antocoagulation in women (warfarin or NOAC) reduces the risk of stroke significantly greater than men
• In general, bleeding risk on anticoagulation is comparable to men.
